Aarhus University Hospital, Skejby

Aarhus 8200

0 studies enrolling now · 3 studies all time

What they study most

Coronary Artery Disease, Pulmonary Arterial Hypertension, Transthyretin Amyloidosis, Transthyretin Gene Mutations

Studies at this site

• The PLATFORM Study: Prospective LongitudinAl Trial of FFRct: Outcome and Resource IMpacts) — Completed
• The Efficacy and Safety of Initial Triple Versus Initial Dual Oral Combination Therapy in Patients With Newly Diagnosed Pulmonary Arterial Hypertension — Completed
• Transthyretin Amyloidosis Outcome Survey (THAOS) — Completed